Thyrocare Technologies Limited
Symbol: THYROCARE.BO
BSE
603.8
INRMarkedspris i dag
50.3318
P/E-forhold
0.9063
PEG Ratio
31.97B
MRK Cap
- 0.00%
DIV Udbytte
Thyrocare Technologies Limited (THYROCARE-BO) Årsregnskaber
Balance
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1400.7 | 1388.4 | 1176.9 | |||||||||
balance-sheet.row.short-term-investments | 0 | 1223 | 1252.1 | 1044.9 | |||||||||
balance-sheet.row.net-receivables | 0 | 856.7 | 944.8 | 513.5 | |||||||||
balance-sheet.row.inventory | 0 | 276.7 | 245.3 | 233.6 | |||||||||
balance-sheet.row.other-current-assets | 0 | 53.2 | 112.8 | 28.4 | |||||||||
balance-sheet.row.total-current-assets | 0 | 2729.4 | 2700.2 | 2404.4 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 1944.3 | 1867.9 | 1600.9 | |||||||||
balance-sheet.row.goodwill | 0 | 1002.8 | 1002.8 | 1002.8 | |||||||||
balance-sheet.row.intangible-assets | 0 | 7.9 | 8.3 | 9.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1010.7 | 1011.1 | 1012.5 | |||||||||
balance-sheet.row.long-term-investments | 0 | 223.1 | 243.8 | 270.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 122.7 | 64.9 | 56.3 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 297 | 188.7 | 113.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 3597.8 | 3376.4 | 3053.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.account-payables | 0 | 239.9 | 165.3 | 250.1 | |||||||||
balance-sheet.row.short-term-debt | 0 | 71.9 | 50 | 30.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 18.3 | 18.3 | 18.6 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 161.2 | 157 | 54.5 | |||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 91.9 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 398.4 | 336.5 | 312.5 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 204 | 165.7 | 234.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.total-liab | 0 | 975 | 810.9 | 1185.2 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 529.3 | 529 | 528.7 | |||||||||
balance-sheet.row.retained-earnings | 0 | 3434.2 | 3568.8 | 2599.2 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1255.9 | 1244.1 | 1225.8 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 123.6 | -76.2 | -80.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 5343 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6327.2 | 6076.6 | 5458 | |||||||||
balance-sheet.row.minority-interest | 0 | 9.2 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 5352.2 | 5265.7 | 4272.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 221 | 209.2 | 211 | |||||||||
balance-sheet.row.total-debt | 0 | 233.1 | 207 | 84.9 | |||||||||
balance-sheet.row.net-debt | 0 | 55.4 | 70.7 | -47.1 |
Pengestrømsopgørelse
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 874.1 | 2279 | 1525.4 | |||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | -247.4 | -731.2 | -522.2 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 211.7 | 23.2 | 16.8 | |||||||||||
cash-flows.row.change-in-working-capital | 0 | 57.9 | -792.2 | -176.5 | |||||||||||
cash-flows.row.account-receivables | 0 | -14.3 | -587.2 | -288.1 | |||||||||||
cash-flows.row.inventory | 0 | -31.4 | -11.7 | -27.4 | |||||||||||
cash-flows.row.account-payables | 0 | 74.2 | -84.8 | 31.5 | |||||||||||
cash-flows.row.other-working-capital | 0 | 29.4 | -108.5 | 107.5 | |||||||||||
cash-flows.row.other-non-cash-items | 0 | 9.7 | 16.6 | 1 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.acquisitions-net | 0 | 30.2 | 42.5 | 42.5 | |||||||||||
cash-flows.row.purchases-of-investments | 0 | -1919.9 | -1730 | -1361.1 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1932.5 | 1593.5 | 1042.1 | |||||||||||
cash-flows.row.other-investing-activites | 0 | 3.8 | 236.6 | 56.8 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -389.9 | -235.7 | -486.6 | |||||||||||
cash-flows.row.debt-repayment | 0 | -55.3 | -53.8 | -25 | |||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.3 | 0.3 | |||||||||||
cash-flows.row.common-stock-repurchased | 0 | -55.3 | -53.8 | -62.6 | |||||||||||
cash-flows.row.dividends-paid | 0 | -793.5 | -793.1 | -528.4 | |||||||||||
cash-flows.row.other-financing-activites | 0 | 42 | 6.3 | -0.1 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -861.8 | -894.1 | -615.8 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | -2.5 | |||||||||||
cash-flows.row.net-change-in-cash | 0 | 41.4 | 4.3 | 44.9 | |||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 177.7 | 136.3 | 132 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 136.3 | 132 | 87.1 | |||||||||||
cash-flows.row.operating-cash-flow | 0 | 1293.1 | 1134.1 | 1147.3 | |||||||||||
cash-flows.row.capital-expenditure | 0 | -436.5 | -378.3 | -266.9 | |||||||||||
cash-flows.row.free-cash-flow | 0 | 856.6 | 755.8 | 880.4 |
Resultatopgørelse række
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 5266.7 | 5888.6 | 4946.2 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 1632.3 | 1696.9 | 1639 | |||||||||
income-statement-row.row.gross-profit | 0 | 3634.4 | 4191.7 | 3307.2 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.operating-expenses | 0 | 2788.2 | 2173.1 | 1895.9 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 4420.5 | 3870 | 3534.9 | |||||||||
income-statement-row.row.interest-income | 0 | 13.8 | 7.1 | 7.9 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 4.4 | 18 | 21.2 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -0.4 | 227.9 | 61.8 | |||||||||
income-statement-row.row.interest-expense | 0 | 23.5 | 23.7 | 8.7 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 387.1 | 338.7 | 302.8 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 865.5 | 2044.2 | 1455.9 | |||||||||
income-statement-row.row.income-before-tax | 0 | 885.9 | 2277.2 | 1524.7 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 242.3 | 515.8 | 393.2 | |||||||||
income-statement-row.row.net-income | 0 | 643.6 | 1761.4 | 1131.5 |
Ofte stillede spørgsmål
Hvad er Thyrocare Technologies Limited (THYROCARE.BO) samlede aktiver?
Thyrocare Technologies Limited (THYROCARE.BO) samlede aktiver er 6327200000.000.
Hvad er virksomhedens årlige omsætning?
Den årlige omsætning er N/A.
Hvad er virksomhedens profitmargin?
Virksomhedens profitmargin er 0.708.
Hvad er virksomhedens frie pengestrøm?
Det frie cash flow er 16.845.
Hvad er virksomhedens nettoprofitmargin?
Nettofortjenstmargenen er 0.118.
Hvad er firmaets samlede omsætning?
Den samlede omsætning er 0.151.
Hvad er Thyrocare Technologies Limited (THYROCARE.BO) nettoresultat (nettoindkomst)?
Nettoresultatet (nettoindkomsten) er 643600000.000.
Hvad er virksomhedens samlede gæld?
Den samlede gæld er 233100000.000.
Hvad er tallet for driftsudgifter?
Driftsudgifterne er 2788200000.000.
Hvad er firmaets likviditet?
Virksomhedens likviditet er 0.000.